Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors
Vicky Mengfei Qin, Nicole M. Haynes, Criselle D’Souza, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63
The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
Kaveh Hadiloo, Siavash Taremi, Mahmood Heidari, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 42
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
Marisa K. Kilgour, Donald Bastin, Seung‐Hwan Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 37
CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
Lusine Hovhannisyan, Carsten Riether, Daniel M. Aebersold, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 11
Combination of CAR‑T cell therapy and radiotherapy: Opportunities and challenges in solid tumors (Review)
Liqiang Zhong, Yi Li, Tobias Achu Muluh, et al.
Oncology Letters (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 18
Chimeric Antigen Receptor T Cells in Glioblastoma—Current Concepts and Promising Future
Rebecca Kringel, Katrin Lamszus, Malte Mohme
Cells (2023) Vol. 12, Iss. 13, pp. 1770-1770
Open Access | Times Cited: 16
B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers
Marco Ventin, Giulia Cattaneo, Luke Maggs, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Nano-constructs targeting the primary cellular energy source of cancer cells for modulating tumor progression
Krishna Yadav, Deependra Singh, Manju Rawat Singh, et al.
OpenNano (2022) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 23
Pomalidomide improves the effectiveness of CAR-T treatment in the relapsed and refractory multiple myeloma or B-cell leukemia/lymphoma with extramedullary disease
Jie Zhao, Hui Yang, Junnan Ge, et al.
Blood Science (2024) Vol. 6, Iss. 2, pp. e00184-e00184
Open Access | Times Cited: 5
Efficient combination of radiotherapy and CAR-T – A systematic review
Wojciech Szlasa, Aleksandra Sztuder, Agnieszka Kaczmar-Dybko, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116532-116532
Open Access | Times Cited: 5
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)
Lele Miao, Juan Zhang, Wei Xu, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status
Asmae Squalli Houssaini, Salma Lamrabet, Jean Paul Nshizirungu, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 655-655
Open Access | Times Cited: 5
Predictors of Radiation Resistance and Novel Radiation Sensitizers in Head and Neck Cancers: Advancing Radiotherapy Efficacy
Aastha Sobti, Heath D. Skinner, Christopher Wilke
Seminars in Radiation Oncology (2025) Vol. 35, Iss. 2, pp. 224-242
Closed Access
Adoptive immune cell therapy for colorectal cancer
Chenxiao Liu, Nan Liu, Tongcun Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer
Uri Amit, Uğur Uslu, Ioannis I. Verginadis, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 31
Open Access | Times Cited: 4
ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights
Alaa M. Ali, John F. DiPersio
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 4
Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects
Mingze He, Dongqi Zhang, Yu Cao, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e19147-e19147
Open Access | Times Cited: 9
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors
Anne Holtermann, Mila Gislon, Martin K. Angele, et al.
BioDrugs (2024) Vol. 38, Iss. 5, pp. 611-637
Open Access | Times Cited: 3
Mechanistic rationales for combining immunotherapy with radiotherapy
Alexander Chi, Nam P. Nguyen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumors
Tianyu Shi, Mengna Sun, Subiyinuer Tuerhong, et al.
Biomaterials (2024) Vol. 309, pp. 122607-122607
Closed Access | Times Cited: 2
Combined treatment of small cell lung cancer using radiotherapy and immunotherapy: Challenges and updates
Zhumin Cao, Kai Deng, Jinxiu Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117727-117727
Closed Access | Times Cited: 2
Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors
Abdolreza Esmaeilzadeh, Kaveh Hadiloo, Marjan Jabbari, et al.
Life Sciences (2023) Vol. 337, pp. 122381-122381
Closed Access | Times Cited: 6
Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy
Minmin Wang, Linzi Jia, Xiangpeng Dai, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 1821-1848
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top